Literature DB >> 12605036

Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma.

Kela Liu1, Chunlai Zuo, Q Kevin Luo, James Y Suen, Ehab Hanna, Chun-Yang Fan.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a multistage process during which adverse genetic alterations accumulate resulting in loss of cell cycle control, selective cell overgrowth, and ultimately formation of malignancy. Among various genetic alterations in HNSCC is increased microsatellite instability (MSI). hMLH1 is one of the major mismatch DNA repair genes, the inactivation of which caused increased MSI in a variety of human cancers including HNSCC. While somatic mutation is a major mechanism of the hMLH1 gene inactivation in hereditary form of human cancer, promoter hypermethylation appears to be primarily involved in the inactivation of the hMLH1 gene in sporadic form of human cancers. In the current study, we analyzed 78 cases of HNSCC for hMLH1 protein expression and promoter hypermethylation by IHC and methylation-specific PCR (MSP). Twenty-four of 78 cases (31%) of HNSCC contained markedly reduced levels of the hMLH1 protein. Based on the IHC results, 8 cases without and 8 with hMLH1 protein expression (total of 16) were further analyzed by MSP. Seven of 8 cases (88%) that were negative for the hMLH1 protein displayed promoter hypermethylation, whereas 7 of 7 cases (100%) strongly positive for the protein were free of promoter methylation. This study confirms our previous conclusion that promoter hypermethylation represents a major mechanism of the hMLH1 gene inactivation in HNSCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605036     DOI: 10.1097/00019606-200303000-00007

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  5 in total

1.  Role of DNA methylation in head and neck cancer.

Authors:  Semra Demokan; Nejat Dalay
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

2.  Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.

Authors:  Dimitrios Koutsimpelas; Warut Pongsapich; Ulf Heinrich; Sylvia Mann; Wolf J Mann; Jürgen Brieger
Journal:  Oncol Rep       Date:  2012-01-09       Impact factor: 3.906

3.  Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome.

Authors:  Annette M Lim; Ida Lm Candiloro; Nicholas Wong; Marnie Collins; Hongdo Do; Elena A Takano; Christopher Angel; Richard J Young; June Corry; David Wiesenfeld; Stephen Kleid; Elizabeth Sigston; Bernard Lyons; Danny Rischin; Benjamin Solomon; Alexander Dobrovic
Journal:  Clin Epigenetics       Date:  2014-12-09       Impact factor: 6.551

4.  Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.

Authors:  Emanuela Taioli; Camille Ragin; Xiao-Hong Wang; Jiangying Chen; Scott M Langevin; Ashley R Brown; Susanne M Gollin; Seymour Garte; Robert W Sobol
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

5.  Expression of hMLH1 and hMSH2 proteins in ameloblastomas and tooth germs.

Authors:  R Bologna-Molina; V Pereira-Prado; C Sánchez-Romero; G Tapia-Repetto; S Soria; M Hernandez; R Gónzalez-Gónzalez; M Molina-Frechero; T Mikami
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.